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ABSTRACT Rad50-interacting protein 1 (Rint1) associates with the DNA damage re-
sponse protein Rad50 during the transition from the S phase to the G2/M phase and
functions in radiation-induced G2 checkpoint control. It has also been demonstrated that
Rint1 is essential in vesicle trafﬁcking from the Golgi apparatus to the endoplasmic retic-
ulum (ER) through an interaction with Zeste-White 10 (ZW10). We have isolated a novel
interaction between Rint1 and the human papillomavirus 16 (HPV16) transcription and
replication factor E2. E2 binds to Rint1 within its ZW10 interaction domain, and we show
that in the absence of E2, Rint1 is localized to the ER and associates with ZW10. E2 ex-
pression results in a disruption of the Rint1-ZW10 interaction and an accumulation of
nuclear Rint1, coincident with a signiﬁcant reduction in vesicle movement from the ER
to the Golgi apparatus. Interestingly, nuclear Rint1 and members of the Mre11/Rad50/
Nbs1 (MRN) complex were found in distinct E2 nuclear foci, which peaked during mid-S
phase, indicating that the recruitment of Rint1 to E2 foci within the nucleus may also re-
sult in the recruitment of this DNA damage-sensing protein complex. We show that ex-
ogenous Rint1 expression enhances E2-dependent virus replication. Conversely, the
overexpression of a truncated Rint1 protein that retains the E2 binding domain but not
the Rad50 binding domain acts as a dominant negative inhibitor of E2-dependent HPV
replication. Put together, these experiments demonstrate that the interaction between
Rint1 and E2 has an important function in HPV replication.
IMPORTANCE HPV infections are an important driver of many epithelial cancers, includ-
ing those within the anogenital and oropharyngeal tracts. The HPV life cycle is tightly
regulated and intimately linked to the differentiation of the epithelial cells that it infects.
HPV replication factories formed in the nucleus are locations where viral DNA is copied
to support virus persistence and ampliﬁcation of infection. The recruitment of speciﬁc
cellular protein complexes to these factories aids efﬁcient and controlled viral replication.
We have identiﬁed a novel HPV-host interaction that functions in the cellular response
to DNA damage and cell cycle control. We show that the HPV E2 protein targets Rad50-
interacting protein 1 (Rint1) to facilitate virus genome replication. These ﬁndings add to
our understanding of how HPV replicates and the host cell pathways that are targeted
by HPV to support virus replication. Understanding these pathways will allow further re-
search into novel inhibitors of HPV genome replication.
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The human papillomavirus (HPV) life cycle is initiated upon infection of undifferen-tiated keratinocytes localized to the basal layer of the stratiﬁed epithelium. Once
the 8-kb double-stranded DNA viral genome has entered the nuclear compartment, the
viral early proteins E1 and E2 are expressed and recruited to the viral origin of
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replication (Ori) to initiate the replication of episomal viral genomes and increase copy
numbers (1–4). This initial and transient ampliﬁcation is poorly understood but pre-
cedes a stage in which HPV genomes are replicated for stable maintenance and
segregation following host cell division (reviewed in reference 5). The expression of the
viral E6 and E7 oncoproteins inhibits cell growth arrest and induces proliferation in
suprabasal keratinocytes (reviewed in reference 6). In the upper layers of the epithe-
lium, E6 and E7 expression levels are attenuated, resulting in host cell differentiation.
This facilitates late promoter activation and the expression of E1E4, resulting in the
ampliﬁcation of replication, and the virus capsid proteins L1 and L2, required for the
packaging of viral genomes. All of these life cycle events are coordinated through
numerous virus-host interactions whereby HPV manipulates important cellular net-
works to support the persistence of infection and efﬁcient life cycle completion.
Manipulation of the cellular DNA damage response (DDR) by HPV was reported
previously. The Mre11-Rad50-Nbs1 (MRN) triprotein complex plays a fundamental role
in sensing double-strand DNA breaks (DSBs) and triggers checkpoint activation, which
is necessary to maintain the integrity of the cellular genome (7, 8). In the absence of
damage, MRN complex proteins are homogeneously localized in the cell nucleus but
are recruited to sites of DNA damage, resulting in the formation of large nuclear foci (8).
The recruitment of the MRN complex to sites of damage initiates the ataxia telangiec-
tasia mutated (ATM) signaling pathway to activate the G2/M checkpoint following DNA
damage (9). This occurs as the MRN complex binds to and activates ATM, which in turn
phosphorylates several effector proteins, including checkpoint protein 2 (Chk2) and p53
(10). It has also been suggested that MRN participates in the ataxia telangiectasia-
related (ATR)-dependent DDR signaling cascade (11).
HPV replication activates the ATM signaling cascade in differentiated keratinocytes,
which is required for viral genome ampliﬁcation. MRN components localize to nuclear
replication foci in both undifferentiated and differentiated keratinocytes (12). This
phenomenon is not unique to HPV; other small DNA viruses target the MRN complex
by altering MRN protein levels, subcellular localization, or both (reviewed in reference
13). For instance, adenovirus 5 (Ad5) infection inhibits the function of the MRN complex
via degradation by the E1b55K/E4orf6 viral protein (9). In addition, the Ad5 E4orf3
protein alters the subcellular localization of the MRN complex; both Mre11 and Nbs1
have been identiﬁed at foci adjacent to Ad5 replication centers (14). HPV replication
centers also recruit other DDR proteins such as phosphorylated histone 2A (-H2AX),
ATM, Chk2, and Rad51 (12, 15–17). It has been suggested that HPVs target these DDR
proteins to allow the formation of viral replication factories and facilitate HPV DNA
ampliﬁcation (16). Indeed, Nbs1 has been shown to contribute to productive HPV
replication not only as a sensor but also as an effector protein during the ATM signaling
cascade (18).
The speciﬁc mechanisms utilized by HPV to manipulate the cellular DDR to facilitate
viral DNA replication during distinct life cycle stages remain largely unknown. Recent
studies indicate that multiple HPV proteins have the ability to alter the cellular DDR.
HPV E7 plays a key role during the formation of HPV replication factories due to its
ability to bind to ATM and induce the activation of this kinase and its major substrate,
Chk2 (12). In addition, the E7 protein interacts with Rad50 and Nbs1 and increases the
levels of these proteins (18). The HPV E1 and E2 proteins cooperate during the initial
stages of viral DNA replication, and their interaction is essential for virus replication (19),
which is unaffected by the activation of the DDR (20, 21). Furthermore, low- and
high-risk HPV E1 proteins promote arrest at the G1/S boundary and trigger the
activation of the ATM/Chk2 pathway by inducing DSBs in cellular DNA (21, 22).
In this study, we show that HPV16 E2 associates with Rad50-interacting protein 1
(Rint1). Rint1 binds to Rad50 during the late S, G2/M, and M phases of the cell cycle and
functions in G2/M checkpoint activation following DNA damage (23). In addition, Rint1
can inhibit telomerase-independent telomere lengthening by mediating the interaction
between Rad50 and the pocket protein family member p130 (24). Rint1 expression is
necessary during early mouse development, and it has been demonstrated that Rint1
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has tumor suppressor activities and is essential for the maintenance of centrosome
integrity and chromosomal stability (25, 26). Indeed, RINT1mutations have been shown
to present an increased risk of breast and Lynch syndrome spectrum cancers (27),
although a larger case-controlled study did not support this ﬁnding (28). Conversely,
RINT1 has been shown to be overampliﬁed in some cancers and capable of inducing
cellular transformation when inappropriately overexpressed, indicating that Rint1 also
has oncogenic properties (29).
Intriguingly, Rint1 function is also important in subcellular vesicle trafﬁcking. The
interaction and cross talk between checkpoint control and vesicular trafﬁcking proteins
were previously suggested in studies on the effect of the organization of the Golgi
apparatus on cellular mitotic entry (30). Both Rint1 and its interacting partner Zeste-
White 10 (ZW10) participate during checkpoint control as well as subcellular trafﬁcking
(23, 31–33). Studies have shown that Rint1 is localized mainly to the endoplasmic
reticulum (ER) (25, 31) and is necessary for membrane trafﬁcking between the ER and
the Golgi apparatus by modulating the recruitment of ZW10 to the syntaxin 18 complex
(31). Rint1 also participates in endosome-to-trans-Golgi network (TGN) trafﬁcking by
interacting with TGN soluble N-ethylmaleimide sensitive fusion protein (NSF) attach-
ment receptors (SNAREs) (34). To determine the function of the interaction between
HPV16 E2 and Rint1 in the HPV life cycle, we have characterized this interaction and
provided evidence that Rint1 participates in E2-dependent viral DNA replication.
RESULTS
HPV16 E2 interacts with Rint1. During experiments designed to identify novel
cellular binding partners of the DNA helicase ChlR1 by a yeast 2-hybrid screen, Rint1
was isolated as a potential candidate (J. L. Parish and E. J. Androphy, unpublished data).
Although attempts to verify this interaction by coimmunoprecipitation (co-IP) of ex-
ogenous proteins in human cells were unfruitful due to an apparent instability of Rint1
in the presence of overexpressed ChlR1, we noticed that the coexpression of bovine
papillomavirus 1 (BPV1) E2, which targets ChlR1 for the stable maintenance of BPV1
genomes (35, 36), was able to stabilize the Rint1 protein in the presence of exogenously
expressed ChlR1. We therefore hypothesized that Rint1 may also be targeted by, and
form a complex with, the papillomavirus E2 protein. To test this, lysates of C33a cells
expressing HPV16 E2 and the hemagglutinin (HA)-tagged Rint1 protein were immuno-
precipitated with HPV16 E2-speciﬁc antibodies, and coimmunoprecipitation of HA-
Rint1 was determined by Western blotting (Fig. 1A). HA-Rint1 was efﬁciently coimmu-
noprecipitated in lysates expressing HPV16 E2 but not in the absence of E2 expression.
Immunoprecipitation with nonspeciﬁc rabbit IgG did not precipitate HA-Rint1, demon-
strating the speciﬁcity of the assay. The reverse coimmunoprecipitation was also
possible; immunoprecipitation with HA-speciﬁc antibodies resulted in the coimmuno-
precipitation of E2 when the two proteins were coexpressed but not when E2 was
expressed alone (Fig. 1B). Coimmunoprecipitation of HA-Rint1 with BPV1 E2 was also
possible, demonstrating that this interaction is likely to be conserved among diverse
papillomavirus types (data not shown). Furthermore, we were able to coimmunopre-
cipitate the HPV16 E2 protein with endogenous Rint1 (Fig. 1C), indicating that this
interaction occurs at physiological levels of Rint1 and that the HA epitope tag fused to
exogenously expressed Rint1 does not induce binding.
To map the E2 binding domain within Rint1, we utilized a series of epitope-tagged
truncated Rint1 proteins (Fig. 2A) and assayed their binding to E2 by a coimmunopre-
cipitation assay. In this assay, E2 bound to the full-length FLAG-tagged Rint1 protein,
conﬁrming the results shown in Fig. 1. E2 bound to amino acids (aa) 1 to 264 of Rint1
(FLAG–Rint1-N) but did not bind to amino acids 200 to 585 (FLAG–Rint1-M) or amino
acids 220 to 792 (FLAG–Rint1-ΔN), indicating that E2 associates with the N-terminal 200
amino acids of Rint1 (Fig. 2B). Interestingly, this binding site is distinct from the Rad50
binding site, which was previously mapped between amino acids 257 and 792 of Rint1
(23) but overlaps the ZW10 binding site (shown to bind to amino acids 1 to 264) (31),
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suggesting that E2 may disrupt the association of Rint1 with ZW10 but not Rad50
(Fig. 2C).
HPV16 E2 relocalizes Rint1 to the nucleus and forms Rint1-associated nuclear
foci. To determine the biological function of the interaction between Rint1 and E2, we
next analyzed the localizations of both proteins by immunoﬂuorescence (IF) analysis.
For these experiments, we used a commercially available antibody validated by West-
ern blotting of cell lysates of untransfected cells to detect endogenous Rint1 and
lysates of cells transfected with increasing amounts of an HA-Rint1 protein expression
plasmid (Fig. 3A). Immunoﬂuorescent staining of methanol-ﬁxed cells revealed that the
subcellular localization of endogenous Rint1 in C33a cells was predominantly perinu-
clear, with some large, prominent nuclear foci being visible (31) (Fig. 3B). To further
demonstrate the speciﬁcity of the antibody, peptide blocking experiments were per-
formed, in which the majority of the ﬂuorescent signal was absent following incubation
of the antibody with a speciﬁc blocking peptide (Fig. 3B).
FIG 1 Coimmunoprecipitation of HPV16 E2 and Rint1. (A and B) C33a cells transfected with HA-Rint1
alone or in combination with an HPV16 E2 expression plasmid were lysed and immunoprecipitated with
an HPV16 E2-speciﬁc antibody (A) or an HA-speciﬁc antibody (B). Total and coimmunoprecipitated
proteins were detected with HA- and HPV16 E2-speciﬁc antibodies. IgG is a nonspeciﬁc isotype-matched
negative-control antibody used for each immunoprecipitation reaction. (C) C33a cells were left untrans-
fected (UT) or transfected with an HPV16 E2 expression plasmid, and lysates were immunoprecipitated
with a Rint1-speciﬁc antibody or nonspeciﬁc IgG. Total and immunoprecipitated proteins were detected
by using Rint1- or HPV16 E2-speciﬁc antibodies. The 10% input for each immunoprecipitation is shown
on the left. All images shown are representative of results from at least three independent experiments.
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FIG 2 Domain mapping of the E2 interaction site within Rint1. (A) Schematic representation of full-length
(FL) Rint1 and truncations used for domain mapping experiments. N, amino acids 1 to 264; M, amino
acids 200 to 585; ΔN, amino acids 220 to 792. (B) C33a cells were transfected with HPV16 E2 and
FLAG-Rint1 expression plasmids (full-length or truncated Rint1 proteins). Cell lysates were immunopre-
cipitated with HPV16 E2-speciﬁc antibody (sheep) or nonspeciﬁc IgG. Total and immunoprecipitated
proteins were detected by using FLAG- or HPV16 E2-speciﬁc antibodies (TVG261). The input of total cell
lysates is shown on the left, which also shows a nonspeciﬁc cross-reacting band to indicate loading (*).
The data shown above are representative of results from four independent experiments. (C) Molecular
model of amino acids 70 to 783 of Rint1 obtained by using Phyre, modeled on the crystal structure of
the Saccharomyces cerevisiae Rint1 homologue Tip20 (53). Amino acids 1 to 69 and 784 to 792 were
excluded from the model, as they do not have signiﬁcant homology to Tip20. The image was produced
by using PyMOL, and the E2/ZW10 (31) binding region is highlighted in dark gray at the N terminus (N).
The Rad50 binding region of Rint1 is contained within the light gray C-terminal (C) region (23).
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FIG 3 HPV16 E2 expression causes nuclear accumulation of Rint1. (A and B) Validation of the Rint1 antibody used
for detection of endogenous Rint1 was performed by Western blot analysis of untransfected (UT) C33a cell lysates and lysates
from cells transfected with increasing amounts of an HA-Rint1-expressing plasmid (A) and IF detection in the absence () or
(Continued on next page)
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The localization pattern of Rint1 was altered in cells expressing HPV16 E2, where an
increase in nuclear Rint1 staining that diffusely colocalized with E2 was observed.
Furthermore, in a subset of cells, Rint1 colocalized with E2 in nuclear foci, which were
brighter, smaller, and present in larger numbers than the nuclear foci observed in the
absence of E2 (Fig. 3C). Analysis of colocalization in E2-expressing cells by using
Manders’ overlap coefﬁcient revealed that 95.4% (standard deviation [SD], 5.3%; n 
56) of the E2 protein colocalized with endogenous Rint1. To determine whether the
relocalization of Rint1 to the nuclear compartment is physiologically relevant, the Rint1
localization in HPV16 genome-containing W12E cells was determined. These cells
maintain100 to 200 HPV16 episomes per cell (37) (data not shown). The Rint1 protein
was clearly present in the nuclear compartment of these cells (Fig. 3D), indicating that
E2 expressed at physiological levels from the viral genome is able to relocate a pool of
Rint1 to the nucleus of infected cells. This apparent relocalization of Rint1 by E2 was
corroborated by subcellular fractionation experiments in which an increase in the
amount of chromatin-bound Rint1 was reproducibly observed in E2-transfected cells
compared to untransfected control cells (Fig. 3E).
To further characterize E2-Rint1 nuclear foci, and to determine whether these foci
were distinct from the larger Rint1 foci observed in untransfected cells (Fig. 3B),
untransfected or E2-transfected cells were costained with E2, Rint1, and Nopp140
antibodies (Fig. 3F). Nopp140 is a nucleolus-speciﬁc protein previously used as a marker
of nucleolar localization (38). In the absence of E2, Rint1 colocalized with Nopp140-
positive foci in the majority of cells, providing evidence that Rint1 associates with
nucleoli. These Rint1-Nopp140-positive foci were also present in E2-expressing cells;
however, smaller Rint1 foci that were E2 positive but Nopp140 negative were also
formed (Fig. 3F). These data provide evidence that E2 relocalizes Rint1 to nuclear foci
that are not associated with nucleoli.
HPV16 E2 disrupts the Rint1-ZW10 interaction. An essential role for Rint1 in
subcellular trafﬁcking, through its interaction with ZW10, has been well documented
(31, 34, 39). To determine whether ZW10 was also maintained in the nucleus by E2, cells
were stained with a ZW10-speciﬁc antibody (Fig. 4A). Interestingly, ZW10 was not
relocalized to the nuclear compartment in E2-expressing cells as was observed with
Rint1, suggesting that E2 disrupts the interaction of Rint1 with ZW10 and results in the
accumulation of the Rint1 protein in the nucleus. To conﬁrm that this is the case, Rint1
and ZW10 protein complexes were analyzed by coimmunoprecipitation in the presence
and absence of E2 protein expression (Fig. 4B). In untransfected cells that do not
express E2, robust coimmunoprecipitation of endogenous ZW10 with Rint1 antibody
was observed. In agreement with our hypothesis, E2 expression in the same cell line
reduced the proportion of ZW10 associated with Rint1 but did not have any effect on
the expression level of either Rint1 or ZW10. Data from three independent repetitions
of this experiment were quantiﬁed by using ImageJ, demonstrating a 75.7%  15.4%
(SD) (P  0.001) reduction in the amount of ZW10 bound to Rint1 in the presence of
E2. These experiments show that E2 efﬁciently disrupts the Rint1-ZW10 interaction,
suggesting that E2 targets the pool of Rint1 protein that is in complex with ZW10 and
functions in subcellular trafﬁcking.
FIG 3 Legend (Continued)
presence () of a Rint1 antibody blocking peptide (B). (C) Localization of E2 and endogenous Rint1 was determined in C33a
cells that were either untransfected or transfected with an HPV16 E2 expression plasmid. Cells were ﬁxed and stained with a
Rint1-speciﬁc antibody (red/gray), E2 TVG261 antibody (green), and the appropriate Alexa Fluor-conjugated secondary
antibodies. Enlarged images are shown on the right. Colocalization was quantiﬁed by using ImageJ to calculate Manders’
overlap coefﬁcient; 95.4% of the E2 protein colocalized with Rint1 (SD, 5.3%; n  56). (D) Rint1 localization (red) and DNA
staining (blue) in HPV16 episome-containing W12E cells. (E) Nuclear accumulation of the Rint1 protein in untransfected and
E2-expressing cells was determined by subcellular fractionation followed by Western blotting of Rint1 and E2 proteins
alongside markers for the cytoplasmic (C) (Grb2), membrane (M) (ERp72), and chromatin-bound (CB) (histone H3) fractions. (F)
Untransfected or E2-transfected cells were costained with E2 (green)-, Rint1 (red)-, and Nopp140 (magenta)-speciﬁc antibodies
to observe nucleolar localization. The white arrows indicate Nopp140-positive nucleoli that also contain the Rint1 protein, and
the white arrowheads indicate E2/Rint1-positive nuclear foci that do not costain with Nopp140. Enlarged images are shown
on the right. Bars, 10 m.
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Given that E2 expression disrupts the Rint1-ZW10 interaction and results in the
accumulation of at least a proportion of endogenous Rint1 protein but not ZW10 in the
nuclear compartment (Fig. 3C and 4) and that Rint1 is essential for vesicle trafﬁcking
through its interaction with ZW10 (31), we hypothesized that this would result in an
attenuation of vesicle movement in E2-expressing cells. To test this, U2OS cells that
stably express the HPV16 E2 protein or the empty vector control (Fig. 5A) (40) were
transfected with a pEGFP-VSVG plasmid, which expresses a temperature-sensitive
mutant vesicular stomatitis virus-encoded glycoprotein (VSVG) fused to enhanced
green ﬂuorescent protein (EGFP) (41). When cells are incubated at 40°C, EGFP-VSVG is
unable to exit the ER. Shifting the cells to 32°C allows movement from the ER to the
Golgi apparatus and ﬁnally to the plasma membrane. In control cells, EGFP-VSVG had
moved to the Golgi apparatus at 30 min, whereas vesicle movement in E2-expressing
cells was signiﬁcantly delayed (P 0.05). This effect was even more dramatic at 60 min;
whereas EGFP-VSVG in control cells had reached the plasma membrane in over 60% of
cells, only a small number of E2-expressing cells had EGFP-VSVG at the plasma
membrane (P  0.001). The majority of these cells still retained EGFP-VSVG at the Golgi
apparatus (Fig. 5B and C).
HPV16 E2 and Rint1 colocalize throughout the cell cycle and are recruited to
nuclear foci during S phase. Since E2 and Rint1 diffusely colocalized in the nucleus of
some E2-transfected cells, while E2 and Rint1 colocalized in distinct nuclear foci in other
cells (Fig. 3C), we hypothesized that these two different phenotypes are cell cycle
dependent. To test this, E2-transfected cells were synchronized at the G1/S boundary by
FIG 4 HPV16 E2 disrupts the Rint1-ZW10 interaction. (A) E2-transfected cells were stained with E2 TVG261 (green),
ZW10-speciﬁc antibodies (red/gray), and the appropriate Alexa Fluor-conjugated secondary antibodies. In both
panels, DNA was stained with Hoechst 33342 (blue). Bar, 5 m. (B) C33a cells were untransfected (UT) or transfected
with an E2-expressing plasmid, and lysates were immunoprecipitated with Rint1-speciﬁc antibodies or an IgG
isotype-matched control. Immunoprecipitates were divided equally and loaded onto 2 separate gels to simulta-
neously detect Rint1 and ZW10, which have similar molecular weights. Rint1, ZW10, E2, and -actin were detected
by Western blotting in the input (left) and immunoprecipitates (right), as indicated. (C) The percentage of ZW10
that coimmunoprecipitated with Rint1 in the absence (untransfected; UT) or presence (E2) of E2 protein expression
was quantiﬁed by densitometry using ImageJ. The data shown are means and standard deviations from 4
independent experiments (***, P  0.001).
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a double-thymidine block and ﬁxed at 0 h (G1/S phase), 4 h (mid-S phase), and 7 h
(G2/M phase) postrelease. Cell synchronization was conﬁrmed by ﬂow cytometry, and
these cells were compared to an asynchronously growing population (Fig. 6A). The
subcellular localization of E2 and endogenous Rint1 was then detected by immuno-
ﬂuorescence staining, and the number of cells containing more than 10 E2/Rint1 foci
(E2/Rint110) at each time point was evaluated. In asynchronous cultures, and in
accordance with our above-described observations, the majority of cells had E2 and
Rint1 distributed homogeneously within the nucleus, and 19.2% (SD, 4.2%) of cells
had distinct E2/Rint1 nuclear foci. Similarly, E2 and Rint1 were uniformly distributed
within the nucleus of the majority of cells synchronized at the G1/S boundary, and
25.0% (SD, 8.7%) of cells contained E2/Rint110-positive foci. Interestingly, the colo-
calization of E2 and Rint1 in distinct nuclear foci was most evident in cells harvested at
mid-S phase, where 42.9% (SD, 3.6%) of cells had E2/Rint110-positive foci. The
proportion of cells with E2/Rint110-positive foci peaked in mid-S phase and was
reduced to 22.7% (SD,1.9%) as cells entered G2/M phase. In addition to the reduction
in the number of cells with 10 E2/Rint1 foci at the G2/M phase, the foci present in
FIG 5 HPV16 E2 causes delayed EGFP-VSVG transport from the ER. U2OS cells stably expressing HPV16 E2 or the
equivalent empty vector control were used to study EGFP-VSVG trafﬁcking. (A) E2 expression was determined by
Western blotting using an HPV16 E2-speciﬁc antibody. Membranes were subsequently stripped, and -actin was
detected as a loading control. (B) E2-expressing or control cells were transfected with the EGFP-VSVG-expressing
plasmid, and cells were incubated at 40°C for 24 h. Cells were then transferred to 32°C to allow vesicle transport,
which was visualized at 0, 30, and 60 min. (C) Quantiﬁcation of VSVG-EGFP localization at each time point. A total
of 200 cells were scored for each time point. The data show the means and standard errors from three independent
experiments.
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these cells were generally smaller than those that had been observed during the mid-S
phase.
Overall, these data demonstrate that HPV16 E2 and endogenous Rint1 colocalize
throughout the cell cycle. Moreover, E2 and endogenous Rint1 are recruited to distinct
nuclear foci, and the formation of these structures is enhanced during S phase.
HPV16 E2 partially colocalizes with MRN complex proteins Mre11 and Nbs1.
Previous reports showed that Rint1 interacts with the DNA repair protein Rad50 (23, 24).
Since Rad50 forms part of the Mre11/Rad50/Nbs1 (MRN) complex, which is important
in DNA damage repair and checkpoint surveillance, we examined whether the mem-
FIG 6 HPV16 E2 and Rint1 colocalize in nuclear foci during S phase. C33a cells were transfected with an HPV16
E2-expressing plasmid and synchronized by a double-thymidine block. Asynchronously growing cells or cells
harvested 0, 4, or 7 h following release were ﬁxed and stained with propidium iodide (PI), and cell cycle proﬁles
were obtained by ﬂow cytometry (left). Cells within the same cultures were ﬁxed at the indicated time points.
Localization of E2 and Rint1 was determined by staining with the E2-speciﬁc TVG261 antibody (green) and Rint1
antibody (red/gray). DNA was stained with Hoechst 33342 (blue). Bar, 5 m. (B) Quantiﬁcation of E2-expressing cells
containing 10 E2/Rint1-positive foci at each time point. A total of 500 cells were scored at each time point. The
data shown are the means and standard deviations from three independent experiments (***, P 0.001 compared
to asynchronous cells).
Campos-León et al. Journal of Virology
March 2017 Volume 91 Issue 5 e02305-16 jvi.asm.org 10
 o
n
 April 4, 2017 by ST ANDREW
S UNIV
http://jvi.asm.org/
D
ow
nloaded from
 
bers of this complex were also recruited to E2-containing foci. C33a cells were trans-
fected with an HPV16 E2 expression plasmid, and the subcellular localization of E2 as
well as endogenous Nbs1, Mre11, and Rad50 was analyzed by immunoﬂuorescence
microscopy following ﬁxation of cells in 20°C methanol. Unfortunately, we were not
able to detect Rad50 due to poor staining with the Rad50-speciﬁc antibody used.
Punctate nuclear staining of Nbs1 and Mre11 was observed in untransfected C33a cells,
as was previously observed for unperturbed cells by using similar ﬁxation methods (42).
Transfection of cells with HPV16 E2, however, resulted in the formation of more
strongly stained Nbs1 and Mre11 nuclear foci that partially colocalized with E2 (Fig. 7A
and B).
Rint1 colocalizes with HPV16 E2/E1 foci in the presence of the viral origin of
replication. The subcellular localization of the HPV16 E1 and E2 proteins was previ-
ously examined by using different epithelial cell lines, and the coexpression of these
viral proteins brings about the formation of discrete nuclear foci, to which proteins that
participate during the DNA damage response have also been shown to be recruited (15,
18, 21, 22, 43). In order to determine whether Rint1 is also present in E2/E1-positive foci,
C33a cells were cotransfected with HPV16 E2 and HPV16 HA-E1 expression plasmids as
well as with a plasmid that contains the HPV16 origin of replication (pOri16M). The
subcellular localization of endogenous Rint1 in HPV16 E2/E1-expressing cells was then
determined by immunoﬂuorescence staining. As expected from previous reports,
HPV16 E1 and E2 colocalized in nuclear foci in the presence of Ori (Fig. 8A). Interest-
ingly, endogenous Rint1 colocalized with E1/E2 foci in the presence of Ori, indicating
that Rint1 may be recruited to nuclear virus replication factories (Fig. 8B).
Our results demonstrate that HPV16 E2 alters the subcellular localization of endog-
enous Rint1 and brings about its relocalization to the nucleus. To rule out the possibility
that E1 contributes to the recruitment of Rint1 to E1/E2 replication factories, cells were
cotransfected with HPV16 HA-E1 expression plasmid and p16OriM only. The localization
of endogenous Rint1 in E1-expressing cells was then determined. While HPV16 E1 was
FIG 7 HPV16 E2 partially colocalizes with the MRN complex proteins Mre11 and Nbs1. C33a cells were
transfected with an HPV16 E2 expression plasmid, ﬁxed in ice-cold methanol, and stained with an
E2-speciﬁc antibody (green). DNA was stained with Hoechst 33342 (blue). (A) Endogenous Nbs1 was
detected with an Nbs1-speciﬁc antibody (red/gray). (B) Endogenous Mre11 was detected with an
Mre11-speciﬁc rabbit antibody (red/gray). Bar, 5 m. Digital zoom is shown at the bottom.
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mainly diffusely localized within the nuclei of transfected cells (Fig. 8C, top), a subset of
cells within the same population had clear nuclear E1 foci (Fig. 8C, bottom). However,
the expression of HPV16 E1 did not change the subcellular localization of endogenous
Rint1, which was predominantly localized to punctate perinuclear ER-associated struc-
tures and nucleoli, as observed in untransfected cells (Fig. 3B).
Rint1 overexpression enhances E2-dependent replication. Our data demonstrate
that Rint1 is present in E2/E1-positive foci (Fig. 8B), which were previously shown to be
viral replication factories (16); we therefore evaluated the effect of Rint1 overexpression
on viral DNA replication. Before performing these experiments, we ﬁrst determined
whether Rint1 expression had any effect on the cell cycle distribution, since an
alteration of cell cycle progression would have an indirect effect on virus replication.
Cells were transfected with full-length Rint1 and the truncated form, Rint1-N, used in
previous experiments, and the cell cycle proﬁle for each sample was determined by
ﬂow cytometry. No effects on cell cycle progression were observed following the
overexpression of full-length or truncated Rint1 (data not shown). Therefore, cells were
FIG 8 Rint1 colocalization to E1/E2 replication foci is E2 dependent. (A) C33a cells were cotransfected
with HPV16 Ori (p16OriM), HPV16 E2, and HPV16 HA-E1 expression plasmids. Cells were ﬁxed, and E2
(green) and HA-tagged E1 (red) were detected with E2- and HA-speciﬁc antibodies, respectively. Cellular
DNA was stained with Hoechst 33342 (blue). (B) Cells were transfected as described above for panel A,
and Rint1 (red) was detected along with E1 (magenta) and E2 (green). (C) Cells were transfected with
p16OriM and HPV16 HA-E1 in the absence of E2, and Rint1 (red) and E1 (magenta) protein localization
was detected as described above for panel B. Bar, 5 m. Digital zoom is shown at the bottom (A and B).
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transfected with HPV16 E1 and HPV16 E2 either alone or in combination with increasing
amounts of HA-tagged Rint1 in the presence of p16OriM. The expression level of each
protein was determined by Western blotting (Fig. 9A), and p16OriM replication was
determined by quantitative PCR (qPCR) (Fig. 9B). While the replication of p16OriM was
minimally detectable in cells transfected with p16OriM alone or cotransfected with
either E1, E2, or Rint1 expression plasmids alone, the coexpression of E1 and E2
dramatically enhanced viral origin replication. The coexpression of increasing amounts
of HA-Rint1 resulted in a dose-dependent increase in Ori levels, providing evidence that
Rint1 stimulates HPV DNA replication (Fig. 9B). In contrast, Rint1 overexpression did not
have any signiﬁcant effect on E2-dependent transcription activation using a synthetic
E2-dependent reporter (data not shown).
Overexpression of the truncated Rint1 protein attenuates E2-dependent virus
replication. Our experiments showed that HPV16 E2 binds to the N-terminal 264 amino
acids of Rint1 (Rint1-N) (Fig. 2), a region that was previously shown to be unable to bind
to Rad50 (23). Since we observed that the MRN complex proteins Mre11 and Nbs1 were
recruited to E2 foci (Fig. 6) and others demonstrated that these proteins are recruited
to HPV replication centers (18), we hypothesized that the overexpression of the E2
binding portion of Rint1 may attenuate virus replication. Cells were therefore trans-
fected with viral Ori, E1, and E2 as described above, alone or in combination with a
plasmid expressing Rint1-N. Protein expression levels were determined by Western
blotting (Fig. 9C), and origin replication was determined by qPCR (Fig. 9D). The
overexpression of Rint1-N signiﬁcantly (P  0.01) inhibited E1/E2-dependent origin
replication. Taken together, these results indicate a role for Rint1 in HPV DNA replica-
tion.
FIG 9 Effect of Rint1 and Rint1-N overexpression on E2-dependent virus replication. C33a cells were transfected with HPV16 Ori (p16OriM), HPV16 E2, and HA-E1
either alone or in combination with increasing amounts of an HA-Rint1 expression plasmid (A and B) or a FLAG–Rint1-N expression plasmid (C and D). (A and
C) Cell lysates were analyzed by Western blotting using HPV16 E2-speciﬁc, HA-speciﬁc (to detect E1 and the full-length Rint1 protein) or FLAG-speciﬁc (to detect
the FLAG–Rint1-N protein) antibodies. Western blots were stripped and reprobed with a -actin-speciﬁc antibody as a loading control. (B and D) Transient DNA
replication of p16OriM was measured by qPCR and compared to a standard curve generated by serial dilution of the puriﬁed plasmid. The data shown are means
and standard deviations from technical replicates (**, P  0.01; ***, P  0.001). The results are the means and standard errors from a single experiment
performed in triplicate and are representative of data from at least three independent repetitions of each experiment.
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DISCUSSION
In this article, we report a novel interaction between the HPV16 E2 protein and the
cellular Rad50-binding protein Rint1. Intriguingly, Rint1 seems to have two very differ-
ent cellular functions. It was originally isolated as a Rad50-binding protein and shown
to play a signiﬁcant role in radiation-induced G2 checkpoint activation (23), a function
that has been conﬁrmed in the ﬁssion yeast homologue damage response protein 1
(Drp1) (44). An essential role for Rint1 in subcellular vesicle trafﬁcking by mediating
interactions between ZW10 or Cog1 and members of the SNARE complex at the ER and
TGN, respectively, has also been documented (31, 34, 45). In our study, the interaction
between HPV16 E2 and Rint1 was mapped to the N-terminal ZW10 binding region of
Rint1, and we provide evidence that E2 disrupts the interaction between ZW10 and
Rint1, resulting in impaired subcellular vesicle trafﬁcking and the accumulation of Rint1
but not ZW10 in the nucleus. A similar reduction in vesicle trafﬁcking following the
overexpression of the truncated Rint1-N protein was described previously (31) and
supports our ﬁndings that E2 indeed affects Rint1 function in vesicle trafﬁcking.
Interestingly, E2 has been shown to associate with other proteins involved in regulating
vesicle movement, suggesting that E2 may have multiple effects on subcellular traf-
ﬁcking (46). Why E2 disrupts cellular vesicle movement is not understood. One possible
explanation is that disruption is required for efﬁcient virus entry. However, although
BPV1 E2 has been shown to be packaged in pseudovirions (47), the presence of E2 in
HPV virions has yet to be proven. It is therefore unknown whether E2 plays any role in
virus entry through its effect on subcellular vesicle trafﬁcking. An alternative explana-
tion is that E2 disrupts vesicle trafﬁcking to attenuate antigen presentation on the
surface of infected cells, thus preventing immune activation. Many other viruses have
been shown to inhibit ER-to-Golgi trafﬁcking to prevent major histocompatibility
complex (MHC) class I presentation, and it will be interesting to determine whether this
is also the case for HPV.
Our data show that endogenous Rint1 colocalizes with E2 nuclear foci, predomi-
nantly in the mid-S phase, and that the recruitment of Rint1 to these foci is not
dependent on the presence of viral DNA or the E1 viral helicase. While the formation
of nuclear foci by the E2 protein expressed in the absence of the HPV origin and the E1
helicase has not been widely reported, our experiments clearly demonstrate that the E2
protein forms nuclear foci in a subset of cells when expressed alone. Similar E2 foci
were demonstrated previously, although the function of these foci was not described
(46). The E2 foci observed in our experiments were more visible following ﬁxation of
cells with ice-cold methanol rather than with paraformaldehyde, which was required to
visualize the Rint1 protein with available antibodies. Methanol ﬁxation can remove
soluble non-chromatin-bound proteins (48), suggesting that there are E2 foci in the
nuclei of some E2-expressing cells but that these foci are less likely to be visible
following ﬁxation with paraformaldehyde, which does not remove soluble nuclear
proteins.
Although Rint1 is known to bind to Rad50 (23, 24), it is not known whether the pool
of Rad50 targeted by Rint1 is associated with the other members of the MRN complex,
Mre11 and Nbs1. We were unable to study the recruitment of Rad50 to E2 foci but
found that both Mre11 and Nbs1 are recruited to nuclear E2 foci, suggesting that the
interaction with Rint1 may mediate the recruitment of the entire MRN complex to E2
foci and that Rad50 is likely to bind Rint1 while existing as part of the MRN complex,
although this is yet to be formally proven. Nonetheless, the recruitment of Rint1, Nbs1,
and Mre11 to nuclear E2 foci suggests the formation of an E2-dependent prereplication
complex containing Rint1 and the associated MRN complex.
It was previously shown that HPV replication foci recruit DNA damage response
proteins such as activated ATM, Chk2, and the MRN complex (15, 18), and the ampli-
ﬁcation of viral DNA in HPV genome-containing cells requires ATM activation (12). The
inhibition of this pathway reduces viral episome copy numbers (48). Our experiments
show that Rint1 is also recruited to replication factories that contain E1 helicase and
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presumably the viral origin of replication. These E1/E2/Rint1 foci were generally larger
than the E2/Rint1 foci observed, indicating that Rint1 recruitment is initiated by E2 but
that virus replication increases the recruitment of Rint1 to replication centers. In
support of this model, E1 was unable to relocalize Rint1 to the nucleus in the absence
of E2, even in cells that had clear E1 foci. Interestingly, E1 expression alone results in the
activation of a DDR, as evidenced by DNA damage marks such as phosphorylated
histone variant H2AX (H2AX) and Chk2 (21, 22). Our data show that Rint1 is not
recruited to these sites of E1-induced damage, providing evidence that DNA damage
caused by E1 does not engage Rint1 and that E2 brings Rint1 to the replication
complex.
In support of the idea that Rint1 is recruited to viral replication factories to regulate
virus replication, we show that Rint1 overexpression stimulates E1/E2-dependent virus
origin replication in a transient virus DNA replication assay. In addition, we demonstrate
that the expression of the truncated Rint1-N protein, which was previously shown to
bind to ZW10 and modulate Rint1 function in vesicle trafﬁcking in a dominant negative
manner (31) but is unable to bind to the Rad50 protein (23), has a dominant negative
effect on HPV DNA replication. We therefore conclude that the suppression of HPV
origin replication following the expression of Rint1-N is due to the disruption of the
association between full-length Rint1 and the associated MRN complex with E2 but not
the disruption of the Rint1-ZW10 interaction, which our experiments show is already
abrogated by the expression of the E2 protein (Fig. 4). We conﬁrmed that the expres-
sion of full-length and truncated Rint1 proteins did not cause cell cycle arrest or delay,
leading us to conclude that Rint1 is recruited to replication foci by E2 to enhance virus
replication rather than indirectly affecting replication by an alteration of cell cycle
progression. Whether this is important in maintenance replication or the ampliﬁcation
of viral genomes in differentiating keratinocytes is a question that we are currently
addressing.
HPV DNA replication induces a cellular DNA damage response that is exploited to
recruit DNA replication complexes to enhance viral DNA replication (reviewed in
reference 49). We show for the ﬁrst time that the Rad50-associated protein Rint1 is
targeted by E2 and recruited to replication factories. Rint1 enhanced virus replication,
and conversely, a dominant negative truncation of Rint1 reduced virus replication.
Further analysis of this interaction in the context of the HPV life cycle is important, but
given the data reported here, it is tempting to speculate that Rint1 plays an important
role in mediating the recruitment of DNA damage response complexes to HPV repli-
cation centers to support virus genome ampliﬁcation.
MATERIALS AND METHODS
Cell culture. C33a cells are HPV-negative human cervical carcinoma-derived keratinocytes grown in
Dulbecco’s modiﬁed Eagle’s medium (DMEM) supplemented with 10% fetal bovine serum (FBS). Stable
U2OS lines containing either the pCMV4 vector or pCMV4-HPV16-E2 (provided by Iain Morgan, Virginia
Commonwealth University), which expresses HPV16 E2, were grown in DMEM supplemented with 10%
FBS and 0.7 mg/ml G418 (40).
Cells were synchronized by a double-thymidine block following incubation in 2 mM thymidine for 16
h and subsequently washed with phosphate-buffered saline (PBS) at 37°C. Cells were grown for 8 h in
fresh growth medium, followed by a second incubation with 2 mM thymidine for 16 h. Asynchronously
growing cells or cells harvested 0, 4, or 7 h following thymidine release were ﬁxed in methanol for IF
analysis or ﬁxed in ethanol and stained with propidium iodide for analysis by ﬂow cytometry as
previously described (35). W12E cells were obtained from Paul Lambert (University of Wisconsin) and
were cultured on -irradiated J2-3T3 ﬁbroblasts in F medium as previously described (37).
Plasmids. Human Rint1 cDNA was ampliﬁed from an oligo(dT)-primed HeLa cDNA library by using
the following primers: 5=-CATGCCATGGAGCTGGGTAGTGAGTGTGTCGCT-3= and 5=-CGGCTCTA
GACCAAAGAAACCTTTTTCTGAAAGACA-3=. Products were digested with NcoI and XbaI and ligated into
pSP65-HA digested with the same restriction enzymes. pSP65-HA-Rint1 was then digested with BamHI
and XbaI, and HA-Rint1 cDNA was ligated into pcDNA3.1 (Promega) to create pcDNA-HA-Rint1, which
expresses the Rint1 protein with an N-terminal HA tag from a cytomegalovirus (CMV) promoter. pOri16M
(pOriM) contains the HPV16 origin of replication (50), and pCMV-E2 encodes the wild-type HPV16 E2
protein. pHPV16-HAE1 encodes the HA-tagged HPV16 E1 protein (51). These constructs were provided
by Iain Morgan, Virginia Commonwealth University. pCMV-FLAG-Rint1-FL (full length) (aa 1 to 792),
pCMV-FLAG-Rint1-N (aa 1 to 264), pCMV-FLAG-Rint1-M (aa 200 to 585), and pCMV-FLAG-Rint1-ΔN (aa 565
to 792) encode FLAG-tagged full-length and truncated Rint1 proteins (31) and were provided by Mitsuo
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Tagaya, Tokyo University of Pharmacy and Life Science, Japan. The plasmid expressing the EGFP-tagged
vesicular stomatitis virus G protein (pEGFP-VSVG) was obtained from Addgene (41).
Antibodies. Primary antibodies used for IF analysis are as follows: mouse anti-HPV16 E2 (TVG 261,
catalogue number ab17185; Abcam), goat anti-Rint1 (N-15, catalogue number SC-19404; Santa Cruz
Biotechnology), rabbit anti-Nopp140 (a gift from Thomas Meier, Yeshiva University), rabbit anti-Mre11
(catalogue number 4895-S; Cell Signaling Technology), rabbit anti-HA (catalogue number ab9110;
Abcam), rabbit anti-Nbs1 (catalogue number NB100-143; Novus Biologicals), and rabbit anti-ZW10
(catalogue number ab21582; Abcam). All secondary antibodies used for IF analysis were Alexa Fluor 488-,
594-, or 647-conjugated antibodies (Life Technologies).
For Western blot analysis, mouse anti-HPV16 E2, mouse anti-HA (HA.11 clone 16B12; Covance), rabbit
anti-HA, goat anti-Rint1, rabbit anti-ERp72 (catalogue number 5033; Cell Signaling), mouse anti-Grb2
(catalogue number SC-8034; Santa Cruz), rabbit anti-histone H3 (catalogue number A300-823A; Bethyl),
rabbit anti-ZW10, mouse -actin (clone AC-15, catalogue number A5441; Sigma-Aldrich), and mouse
anti-FLAGM2 (catalogue number F1804; Sigma-Aldrich) primary antibodies were used, which were
detected with horseradish peroxidase (HRP)-conjugated secondary antibodies (Thermo Scientiﬁc).
For co-IP, sheep anti-HPV16 E2 (52), mouse anti-HA, mouse anti-FLAGM2, rabbit anti-HA, and goat
anti-Rint1 were used. Sheep preimmune serum (Dundee Cell Products), normal rabbit IgG (catalogue
number SC-2027; Santa Cruz Biotechnology), mouse anti-HA, and normal mouse IgG (catalogue number
SC-2025; Santa Cruz Biotechnology) were used as negative-control antibodies.
Coimmunoprecipitation. C33a cells (3 	 106) were seeded into 100-mm-diameter tissue culture
dishes and transfected by using X-tremeGENE HP (Roche) at a DNA-to-reagent ratio of 1:2. At 24 h
posttransfection, the cells were lysed, and coimmunoprecipitations performed as previously described
(36).
Immunoﬂuorescence. C33a cells were plated onto coverslips at 3 	 106 cells/100-mm dish and
transfected by using the Lipofectamine 2000 reagent (Life Technologies) at a DNA-to-reagent ratio of 1:3.
At 24 h posttransfection, cells were ﬁxed with 20°C methanol for 4 min at 20°C and washed three
times with PBS. Cells were permeabilized with 0.2% Triton X-100–PBS for 15 min at 4°C and washed three
times with PBS. Samples were blocked with 3% bovine serum albumin (BSA)–PBS for 1 h at room
temperature and washed twice with PBS before incubation with a primary antibody diluted in block
solution overnight at 4°C in a humidiﬁed chamber. For Rint1 antibody peptide blocking experiments, 0.2
g primary antibody was incubated with 2 g blocking peptide (catalogue number SC-19404P; Santa
Cruz) in a total volume of 100 l PBS for 1 h at room temperature (RT) before further dilution in blocking
buffer for immunoﬂuorescence analysis. The coverslips were washed with PBS and incubated with
secondary antibody diluted in block solution for 1 h at RT. Cellular DNA was stained with 10 g/ml
Hoechst 33342 (Life Technologies) in PBS for 30 min at room temperature. The coverslips were mounted
by using the ProLong Gold antifade reagent (Life Technologies). Images were acquired by using a Nikon
Eclipse E600 confocal laser scanning microscope and the Leica DC200 integrated digital camera and
software. For quantiﬁcation of colocalization, confocal images were acquired from three independent
experiments and analyzed by using ImageJ (v.1.50c). Manders’ overlap coefﬁcient was used to describe
the fraction of E2 that colocalized with endogenous Rint1 for each image, and data were used to
calculate the mean percent overlap.
Subcellular fractionation. Subconﬂuent C33a cells in 100-mm dishes were transfected with an
HPV16 E2-expressing plasmid or mock transfected. Cells were harvested 24 h following transfection, and
subcellular fractions were isolated by using a subcellular protein fractionation kit (Thermo Scientiﬁc)
according to the manufacturer’s instructions. Equal amounts of each fraction were separated by
SDS-PAGE, and proteins were detected by Western blotting.
Protein transport assays. U2OS cells stably expressing the HPV16 E2 protein or an empty vector
control (40) were grown on coverslips. Cells were transfected with pEGFP-VSVG by using X-tremeGENE
HP and incubated at 40°C for 24 h. Cells were then transferred to 32°C to stimulate vesicle transport, and
individual coverslips were ﬁxed in 3.7% paraformaldehyde (PFA) in PBS at 0, 30, and 60 min. Microscopic
analysis was performed with a Nikon E600 epiﬂuorescence microscope, and images were captured by
using a Nikon DXM1200F digital camera.
DNA replication assay. Transient DNA replication assays were performed as described previously
(52). In brief, 2.5	 105 C33a cells were seeded into each well of a 6-well plate and transfected in triplicate
with 50 ng p16OriM, 500 ng pHPV16-HAE1, and 10 ng pCMV-E2 in the absence or presence of 100, 250,
and 500 ng pcDNA-HA-Rint1. For each experiment, one well was harvested for protein expression
analysis by Western blotting using urea lysis buffer (8 M urea, 50 mM Tris-HCl [pH 7.5], and 14 mM
-mercaptoethanol) and sonication. DNA was extracted from the remaining duplicate wells by Hirt
extraction. Puriﬁed DNA was digested with DpnI. The amount of replicated pOri16M was quantiﬁed by
qPCR using Sensimix Sybr (Bioline) and an MXPro3005 PCR machine (Agilent) as previously described
(50, 52).
Statistical analysis. Where indicated, data were analyzed by using two-tailed, unpaired Student’s t
test.
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